全球领先的新经济产业第三方数据挖掘与分析机构
关于“寻医问药”的报告
-
-
-
-
-
-
艾媒咨询 | 2025年中国夜间用药市场发展状况与消费者行为调查数据
在消费观念升级与健康意识觉醒的双重驱动下，中国夜间用药市场正迎来结构性变革。根据全球领先的新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年中国夜间用药市场发展状况与消费者行为调查数据》数据显示，2024年人均医疗保健支出为2547元。未来，随着科技进步带来医疗服务与产品的升级，中国人均医疗保健支出有望继续保持增长趋势。在2025年中国夜间用药消费者夜间购药药品种类中，感冒发烧药品占比31.22%，是所有药品中占比最高的。肠胃消化药品夜间购药占比第二，达到25.04%。整体来看，夜间购药以感冒发烧和肠胃消化等常见病症药品为主。在2025年中国夜间用药消费者夜间线上买药原因中，“夜间外出买药不安全”，达到63.51%。其次是“有些药品不好意思直接买/保护购药者隐私”，占比43.24%，说明夜间线上买药的安全性和隐私保护是夜间用药消费者的主要考虑因素。艾媒咨询分析师认为，未来中国夜间用药市场将呈现三大趋势：一是产品向天然成分、低副作用方向迭代，中药夜间用药市场潜力有望进一步释放；二是渠道融合加速，线上线下一体化的 “夜间健康服务圈” 将成为主流；三是智能化服务深化，通过 AI 问诊、智能药盒等技术提升用药安全性与便利性。企业需聚焦细分场景需求，加强产品创新与服务赋能，推动夜间用药市场向规范化、专业化方向发展。
Driven by the dual impetus of the upgrading of consumption concepts and the awakening of health awareness, the night-time medication market in China is undergoing a structural transformation. According to the latest "iiMedia Report | Survey data on the development status and consumer behavior of China's nighttime medication market in 2025" released by iiMedia Research, a leading third-party data mining and analysis institution for the new economy industry worldwide, the per capita healthcare expenditure in 2024 was 2,547 yuan. In the future, with the upgrading of medical services and products brought about by technological progress, China's per capita healthcare expenditure is expected to continue to grow. In 2025, among the types of medicines purchased by Chinese consumers at night, cold and fever medicines accounted for 31.22%, which was the highest proportion among all medicines. The proportion of night-time purchases of gastrointestinal digestion drugs ranked second, reaching 25.04%. Overall, when purchasing medicine at night, the main focus is on common conditions such as colds, fevers, and gastrointestinal disorders. Among the reasons why Chinese consumers purchase medicine online at night in 2025, "It is not safe to buy medicine outside at night" accounted for 63.51%. The second is "Some medicines are too embarrassing to be purchased directly/protecting the privacy of the purchasers", accounting for 43.24%, indicating that the safety and privacy protection of online medicine purchases at night are the main considerations for consumers taking medicine at night. Analysts from iiMedia Research believe that the future night medicine market in China will present three major trends: First, products will evolve towards natural ingredients and low side effects, and the potential of the traditional Chinese medicine night medicine market is expected to be further released; Second, the integration of channels is accelerating, and the "nighttime health service circle" that integrates online and offline will become the mainstream. Third, intelligent services have been deepened, and the safety and convenience of medication have been enhanced through technologies such as AI consultation and smart medicine boxes. Enterprises need to focus on the demands of specific scenarios, enhance product innovation and service empowerment, and promote the development of the night medication market towards standardization and professionalization. -
艾媒咨询|2021全球及中国大健康产业运行大数据及决策分析报告
本报告研究涉及企业/品牌/案例：阿里健康，联合丽格，恒瑞医药，白云山，平安好医生，111集团，新氧，药明巨诺，盘龙药业，先导药业，好大夫在线，优健康，春雨医生，丁香医生，微医
受到人口老龄化、居民患病比例增加等因素影响，国家医疗费用支出不断增加，属于刚性需求；同时，随着人们对健康标准的不断提高以及互联网医疗技术的发展，大健康产业会在相当长的时期内持续保持增长态势。数据显示，2020年中国的大健康产业营收规模超过7万亿元，预计2021年将达8万亿元，增幅达8.1%。其中，得益于大健康产业发展以及疫情期间医药需求增长，生物制药、医疗器械两大细分领域表现良好，成为2020年中国投资热度较高的新经济行业，投资项目金额分别为919亿元和273亿元。
Affected by the aging population and the increasing proportion of residents, the national medical expenditure is increasing, which belongs to the rigid demand; At the same time, with the continuous improvement of people's health standards and the development of internet medical technology, the big health industry will continue to grow for a long time. According to the data, the revenue of China's big health industry will exceed 7 trillion yuan in 2020, and it is expected to reach 8 trillion yuan in 2021, an increase of 8.1%. Among them, thanks to the development of big health industry and the growth of pharmaceutical demand during the epidemic period, biopharmaceuticals and medical devices have performed well, becoming China's new economy industry with high investment enthusiasm in 2020, with investment projects of 91.9 billion yuan and 27.3 billion yuan respectively. -
-
- 1
- 2
- 3
- 4
- 5
- 6
- 54
